SCHEMBL5242986

SCHEMBL5242986

CNC(CCN(C)Cc1ccc(-c2ccc(OC)cc2)cc1)c1nsc2ccccc12

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SMPD1 P17405 1/20 0.41
EPAS1 Q99814 1/20 0.40
TSHR P16473 1/20 0.39
ACKR3 P25106 2/20 0.38
SIGMAR1 Q99720 1/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
PRMT1 Q99873 2/20 0.37
ACP1 P24666 1/20 0.36
PTPN1 P18031 1/20 0.35
ACHE P22303 1/20 0.35
KDM4E B2RXH2 1/20 0.35
NPC1 O15118 1/20 0.35
PKM P14618 1/20 0.35
RAB9A P51151 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
TP53 P04637 1/20 0.35
MAPT P10636 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2977372 0.86 SMPD1 (0.43) SMPD1EPAS1TSHRACKR3SIGMAR1
SCHEMBL13202874 0.77 EPAS1 (0.50) SMPD1EPAS1TSHRACKR3SIGMAR1
SCHEMBL2977889 0.76 SMPD1 (0.50) SMPD1EPAS1TSHRACKR3SIGMAR1
SCHEMBL5282322 0.75 EPAS1 (0.42) EPAS1KMT2AACP1KDM4ENPC1
SCHEMBL2966689 0.73 MEN1 (0.45) EPAS1MEN1KMT2ASMN1; SMN2TP53
SCHEMBL2969567 0.71 KMT2A (0.43) EPAS1MEN1KMT2ANPC1RAB9A
SCHEMBL6109034 0.69 EPAS1 (0.40) EPAS1TSHRMEN1KMT2APTPN1
SCHEMBL2977932 0.67 EPAS1 (0.45) EPAS1TSHRACKR3SIGMAR1TP53
SCHEMBL2977514 0.65 CASR (0.41) EPAS1MEN1KMT2AACP1KDM4E
SCHEMBL2975434 0.65 EPAS1 (0.46) EPAS1TSHRACKR3SIGMAR1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1853573-A1 BENZISOTHIAZOLES USEFUL FOR TREATING OR PREVENTING HCV INFECTION Rigel Pharmaceuticals, Inc. (US) 2007-11-14 EP disclosed
WO-2006091858-A1 BENZISOTHIAZOLES USEFUL FOR TREATING OR PREVENTING HCV INFECTION RIGEL PHARMACEUTICALS, INC. (US) 2006-08-31 WO disclosed